🇺🇸 FDA

P1 · Therapeutic area intelligence

Oncology patent intelligence

Anticancer agents, immuno-oncology, ADC, and oncology patent filings — grants, expirations, and assignee activity.

Patents
1,930

Quick answer

1,930 US pharmaceutical patents in our index match Oncology title keywords (A61K/A61P). Cross-link to related drug therapeutic-area hubs and company patent portfolios for full IP context.

  1. US 6040334

    Use of inhibitors of 3-hydroxy-3-methylglutaryl coenzyme a reductase as a modality in cancer therapy

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Mar 21 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 16 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  2. US 6037337

    Use of the enantiomers of ifosfamide in antitumor therapy for reducing side effects

    Darwin Discovery Limited · Granted Tue Mar 14 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 09 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  3. US 6037376

    Methods for therapy of cancer

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue Mar 14 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 09 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  4. US 6033905

    Gibbon ape leukemia virus-based retroviral vectors

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue Mar 07 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 02 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  5. US 6025328

    Antitumor agents

    The Regents of the University of California · Granted Tue Feb 15 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 10 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  6. US 6017524

    Inhibiting the growth p53 deficient tumor cells by administering the p53 gene

    The Board of Regents of the University of Texas System · Granted Tue Jan 25 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 20 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  7. US 6017962

    Method of depletion of methionine in plasma and solid tumors and uses thereof

    The Board of Regents of the University of Texas System · Granted Tue Jan 25 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 20 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  8. US 6015811

    Antitumor Chrysene derivatives

    The Board of Regents of the University of Texas System · Granted Tue Jan 18 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 13 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  9. US 6015542

    Radioimmunotherapy of lymphoma using anti-CD20 antibodies

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Jan 18 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 13 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  10. US 6013807

    Antitumor tetracyclic compounds

    University College Cardiff Consultants Limited · Granted Tue Jan 11 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 06 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

Frequently asked questions

How many Oncology patents are indexed?

1,930 patents match our Oncology classifier (title keywords in USPTO records).

Is this legal or medical advice?

No — patent intelligence is for professional reference. Verify expiration and FTO with qualified patent counsel and primary USPTO records.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.